win 57273 has been researched along with piperacillin in 1 studies
Studies (win 57273) | Trials (win 57273) | Recent Studies (post-2010) (win 57273) | Studies (piperacillin) | Trials (piperacillin) | Recent Studies (post-2010) (piperacillin) |
---|---|---|---|---|---|
23 | 0 | 0 | 3,180 | 448 | 1,042 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Echols, RM; Robbiano, EM; Venezia, RA; Yocum, DM | 1 |
1 other study(ies) available for win 57273 and piperacillin
Article | Year |
---|---|
Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Drug Therapy, Combination; Fluoroquinolones; Fusobacterium; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Quinolones; Tazobactam | 1990 |